US Broker Ratings

GeneDx Holdings Corp. (WGS) Investor Outlook: A Promising 62% Upside Potential in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Stamford, Connecticut, this..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 20.35% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing significant attention in the biotechnology sector with its robust portfolio of novel oral small molecule therapeutics aimed at addressing..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 41.75% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a prominent player in the biotechnology sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in..

Astrana Health Inc. (ASTH) Investor Outlook: Unpacking the 35.52% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company, has been a subject of interest for investors seeking exposure in the healthcare sector. With its market..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Unpacking a 52.47% Upside Potential in Biotech

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is capturing investor attention with its robust growth potential in the biotechnology sector. As a clinical-stage pharmaceutical company, Centessa is focused..

Celldex Therapeutics (CLDX) Investor Outlook: Analysts See Over 100% Upside Potential

For investors seeking promising opportunities in the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents a compelling case. This New Jersey-based biopharmaceutical company is dedicated to..

Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth

Sotera Health Company (SHC), a key player in the healthcare sector specializing in diagnostics and research, stands out for its strategic positioning and growth potential. With..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A 198% Potential Upside for Investors

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology firm specializing in the development of oral small-molecule and injectable protein therapeutics for rare diseases, is capturing investor attention..

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling an 89% Potential Upside in Biotechnology

Immunocore Holdings plc (IMCR), a leading name in the biotechnology sector, is capturing investor attention with its robust pipeline of immunotherapies and a striking potential upside..

MannKind Corporation (MNKD) Stock Analysis: Why a 72% Upside Could Attract Investors

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company specializing in therapeutic products for endocrine and orphan lung diseases, has recently captured the attention of investors with its..

Acadia Healthcare (ACHC) Stock Analysis: Is a 25% Upside Worth the Risk?

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a key player in the healthcare sector, specifically within the medical care facilities industry. Known for its comprehensive range..

Select Medical Holdings Corp (SEM) Stock Analysis: A 21% Upside Potential in Healthcare

Select Medical Holdings Corp (NYSE: SEM) is garnering attention from investors as a notable player in the healthcare sector, specifically within the medical care facilities industry...

Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 22.82% Upside Potential

For investors seeking opportunities in the dynamic biotechnology sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presents a compelling case. With a robust pipeline of biopharmaceutical assets, Ligand..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 29.79% Upside Potential in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the medical devices industry with its innovative solutions and robust market presence. Based in Newburyport, Massachusetts, the..

BGM Group Ltd. (BGM) Stock Analysis: Navigating the Complexities of a Volatile Market with Innovative Healthcare Products

BGM Group Ltd. (BGM) operates in the highly competitive healthcare sector, focusing on the drug manufacturing industry, specializing in both specialty and generic medications. Based in..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Navigating Biotech Innovation with a 22.59% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a compelling player in the biotechnology sector, commanding attention with a robust market capitalization of $9.32 billion. Specializing in the..

CONMED Corporation (CNMD): Stock Analysis Reveals 18% Potential Upside Amidst Healthcare Sector Dynamics

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector, has been making waves with its specialized focus on medical devices designed for surgical procedures...

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy with 43.5% Revenue Growth

Alignment Healthcare, Inc. (ALHC), a prominent player in the healthcare plans industry, has garnered significant attention from investors, thanks to its impressive revenue growth and a..

Liquidia Corporation (LQDA) Investor Outlook: A Biotech Stock Riding High on 1,121.70% Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) has captured the spotlight with its remarkable revenue growth of 1,121.70%, positioning itself as a notable player in the biotechnology sector. Based..

Envista Holdings Corporation (NVST) Investor Outlook: Navigating a 11.50% Revenue Growth in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) stands out in the healthcare sector as a significant player in the medical instruments and supplies industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds